Loading...
MRD evaluation of AML in clinical practice: are we there yet?
MRD technologies increase our ability to measure response in acute myeloid leukemia (AML) beyond the limitations of morphology. When applied in clinical trials, molecular and immunophenotypic MRD assays have improved prognostic precision, providing a strong rationale for their use to guide treatment...
Na minha lista:
| Udgivet i: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913462/ https://ncbi.nlm.nih.gov/pubmed/31808906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000060 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|